Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

This study is currently recruiting participants.
Verified July 2012 by Yale University
Sponsor:
Collaborator:
Stanley Medical Research Institute
Information provided by (Responsible Party):
Mohini Ranganathan, Yale University
ClinicalTrials.gov Identifier:
NCT00588731
First received: December 29, 2007
Last updated: July 17, 2012
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)